Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Beckley Psytech developing psychedelic medicines for neurological and psychiatric disorders

Beckley Psytech developing psychedelic medicines for neurological and psychiatric disorders

Beckley Psytech's Cosmo Mellen tells Proactive London they're a young company born out of the Beckley Foundation - one of the world leaders in psychedelic research. He says they're a drug development platform focused on developing psychedelic drugs for neurological and psychiatric disorders for patients in need. ''We're building off the foundation's early work and taking the research through the full blown pharmaceutical drug development process to become licensed pharmaceuticals for patients''.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK